Endometriosis is a pain…literally.The condition causes tissue that normally lines the inside of the uterus to grow outside your uterus. The tissue builds up with your menstrual cycle and sheds. With Endometriosis the tissue cannot shed normally, and can cause internal bleeding and scarring, leading to pain and potential fertility issues. Other symptoms can include … Read more
The FDA has just approved BIJUVA, an oral hormone therapy for moderate to severe vasomotor symptoms (also known as hot flashes) due to menopause. This is the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single capsule.Menopause is a naturally occurring transition for women with an average onset age … Read more
On September 14, 2018 the FDA approved AJOVY (fremanezumab-vfrm) injection for the preventative treatment of migraines in adults. The medication is an injectable calcitonin-gene-related peptide (CGRP) antagonist. This is the second anti-CGRP treatment that has recently been approved. This treatment is available in both quarterly and monthly injections. AJOVY can be self-administered or administered in … Read more
Seattle Clinical Research Center is pleased to announce that the FDA has approved a new treatment for axillary hyperhidrosis, also known as excessive underarm sweating. This is a chronic skin condition that affects approximately 10 million people in the United States and causes people to sweat more than what is necessary for normal thermal regulation. … Read more
Seattle Clinical Research Center is excited to announce that the FDA has approved Aimovig, a new treatment developed specifically for migraine headache prevention. Migraine is a debilitating condition that impacts 38 million patients in the United States. Seattle Clinical Research Center conducted one of the pivotal clinical trials involved in the approval process. Aimovig is … Read more
Intrarosa (prasterone) was recently FDA approved to treat moderate to severe painful sexual intercourse (dyspareunia) caused by vulvar and vaginal atrophy (VVA). VVA is a common condition affecting up to 50% of postmenopausal women that results from the loss of estrogen during menopause. This causes the walls of the vagina and surrounding tissues to become … Read more
On July 24th, 2018 the US Food and Drug Administration (FDA) approved Elagolix for the treatment of moderate to severe pain associated with endometriosis. Dr. Robin Kroll, director of Seattle Clinical Research Center has conducted over a dozen clinical trials with the newly approved endometriosis treatment, Orilissa. The drug, Elagolix — now marketed as Orilissa … Read more
This month, Flibanserin, commonly referred to as “female Viagra,” goes to the full Food and Drug Administration for a vote of approval. In early June, a federal advisory committee to the FDA recommended approval. The final vote is due on or before August 18. The entire concept of Female Sexual Dysfunction (FSD) is controversial. Does … Read more
The Cancer Risk Awareness Survey, conducted by the American Institute for Cancer Research (referenced here), demonstrates that we Americans aren’t always aware of things that have been proven to decrease our risk of cancer, and sometimes do things we think decrease our risk of cancer, but have not been proven to do so. But they neglect to mention a very … Read more
Birth control pills were first released in the 1960s, and since then the variety and choice in contraception has only expanded. Picking what’s right for you can be a bit overwhelming and confusing, but at Seattle Clinical Research Center we want you to be informed so we’ve put together a brief summary of the popular … Read more